329 related articles for article (PubMed ID: 17598875)
1. An individual with Gilles de la Tourette syndrome and Smith-Magenis microdeletion syndrome: is chromosome 17p11.2 a candidate region for Tourette syndrome putative susceptibility genes?
Shelley BP; Robertson MM; Turk J
J Intellect Disabil Res; 2007 Aug; 51(Pt 8):620-4. PubMed ID: 17598875
[TBL] [Abstract][Full Text] [Related]
2. A patient with both Gilles de la Tourette's syndrome and chromosome 22q11 deletion syndrome: clue to the genetics of Gilles de la Tourette's syndrome?
Robertson MM; Shelley BP; Dalwai S; Brewer C; Critchley HD
J Psychosom Res; 2006 Sep; 61(3):365-8. PubMed ID: 16938515
[TBL] [Abstract][Full Text] [Related]
3. [Genetic linkage analysis of Gilles de la Tourette Syndrome in a Colombian family].
García-Cerén JJ; Valencia-Duarte AV; Cornejo JW; Carrizosa J; Cuartas JM; Zuluaga-Espinosa NA; Bedoya G; Ruiz-Linares A
Rev Neurol; 2006 Feb 16-28; 42(4):211-6. PubMed ID: 16521059
[TBL] [Abstract][Full Text] [Related]
4. Detection and delineation of an unusual 17p11.2 deletion by array-CGH and refinement of the Smith-Magenis syndrome minimum deletion to approximately 650 kb.
Schoumans J; Staaf J; Jönsson G; Rantala J; Zimmer KS; Borg A; Nordenskjöld M; Anderlid BM
Eur J Med Genet; 2005; 48(3):290-300. PubMed ID: 16179224
[TBL] [Abstract][Full Text] [Related]
5. The genetic susceptibility to Gilles de la Tourette syndrome in a large multiple affected British kindred: linkage analysis excludes a role for the genes coding for dopamine D1, D2, D3, D4, D5 receptors, dopamine beta hydroxylase, tyrosinase, and tyrosine hydroxylase.
Brett PM; Curtis D; Robertson MM; Gurling HM
Biol Psychiatry; 1995 Apr; 37(8):533-40. PubMed ID: 7619976
[TBL] [Abstract][Full Text] [Related]
6. The Gilles de la Tourette syndrome: a principal component factor analytic study of a large pedigree.
Robertson MM; Cavanna AE
Psychiatr Genet; 2007 Jun; 17(3):143-52. PubMed ID: 17417057
[TBL] [Abstract][Full Text] [Related]
7. Neuroreceptor subunit genes and the genetic susceptibility to Gilles de la Tourette syndrome.
Brett PM; Curtis D; Robertson MM; Gurling HM
Biol Psychiatry; 1997 Nov; 42(10):941-7. PubMed ID: 9359981
[TBL] [Abstract][Full Text] [Related]
8. Mood disorder in a patient with Smith-Magenis syndrome: a case report.
Bersani G; Russo D; Limpido L; Marconi D
Neuro Endocrinol Lett; 2007 Feb; 28(1):7-10. PubMed ID: 17277733
[TBL] [Abstract][Full Text] [Related]
9. The Gilles de la Tourette syndrome and obsessional disorder.
Robertson MM
Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():69-82; discussion 82-4. PubMed ID: 1806636
[TBL] [Abstract][Full Text] [Related]
10. Vomiting and retching in Gilles de la Tourette syndrome: a report of ten cases and a review of the literature.
Rickards H; Robertson MM
Mov Disord; 1997 Jul; 12(4):531-5. PubMed ID: 9251071
[TBL] [Abstract][Full Text] [Related]
11. Familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering.
Pauls DL; Leckman JF; Cohen DJ
J Am Acad Child Adolesc Psychiatry; 1993 Sep; 32(5):1044-50. PubMed ID: 8407750
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of risperidone treatment in Smith-Magenis syndrome (del 17 pll. 2).
Niederhofer H
Psychiatr Danub; 2007 Sep; 19(3):189-92. PubMed ID: 17914318
[TBL] [Abstract][Full Text] [Related]
13. The psychopathological spectrum of Gilles de la Tourette syndrome.
Cavanna AE; Rickards H
Neurosci Biobehav Rev; 2013 Jul; 37(6):1008-15. PubMed ID: 23131314
[TBL] [Abstract][Full Text] [Related]
14. Genomic organisation of the approximately 1.5 Mb Smith-Magenis syndrome critical interval: transcription map, genomic contig, and candidate gene analysis.
Lucas RE; Vlangos CN; Das P; Patel PI; Elsea SH
Eur J Hum Genet; 2001 Dec; 9(12):892-902. PubMed ID: 11840190
[TBL] [Abstract][Full Text] [Related]
15. [The genetics of Gilles de la Tourette syndrome].
Bertelsen B; Melchior L; Debes NM; Skov L; Brøndum-Nielsen K; Tümer Z
Ugeskr Laeger; 2012 Feb; 174(8):484-7. PubMed ID: 22348669
[TBL] [Abstract][Full Text] [Related]
16. Atypical Gilles de la Tourette Syndrome with beta-mannosidase deficiency.
Sedel F; Friderici K; Nummy K; Caillaud C; Chabli A; Dürr A; Lubetzki C; Agid Y
Arch Neurol; 2006 Jan; 63(1):129-31. PubMed ID: 16401745
[TBL] [Abstract][Full Text] [Related]
17. Breakpoint sequences of an 1;8 translocation in a family with Gilles de la Tourette syndrome.
Matsumoto N; David DE; Johnson EW; Konecki D; Burmester JK; Ledbetter DH; Weber JL
Eur J Hum Genet; 2000 Nov; 8(11):875-83. PubMed ID: 11093278
[TBL] [Abstract][Full Text] [Related]
18. [Smith-Magenis syndrome: a report of two new cases and an approximation to their characteristic behavioural phenotype].
Blanco-Barca O; Gallego-Blanco M; Ruiz-Ponte C; Barros-Angueira F; Esquete-López C; Eirís-Puñal J; Castro-Gago M
Rev Neurol; 2004 Jun 1-15; 38(11):1038-42. PubMed ID: 15202082
[TBL] [Abstract][Full Text] [Related]
19. The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation.
Cavanna AE; Schrag A; Morley D; Orth M; Robertson MM; Joyce E; Critchley HD; Selai C
Neurology; 2008 Oct; 71(18):1410-6. PubMed ID: 18955683
[TBL] [Abstract][Full Text] [Related]
20. Association of AADAC Deletion and Gilles de la Tourette Syndrome in a Large European Cohort.
Bertelsen B; Stefánsson H; Riff Jensen L; Melchior L; Mol Debes N; Groth C; Skov L; Werge T; Karagiannidis I; Tarnok Z; Barta C; Nagy P; Farkas L; Brøndum-Nielsen K; Rizzo R; Gulisano M; Rujescu D; Kiemeney LA; Tosato S; Nawaz MS; Ingason A; Unnsteinsdottir U; Steinberg S; Ludvigsson P; Stefansson K; Kuss AW; Paschou P; Cath D; Hoekstra PJ; Müller-Vahl K; Stuhrmann M; Silahtaroglu A; Pfundt R; Tümer Z
Biol Psychiatry; 2016 Mar; 79(5):383-391. PubMed ID: 26444075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
